Institute For Clinical And Experimental Medicine

This pilot study tested a new combination of two drugs, Alemtuzumab and Infliximab, given right after a kidney transplant to prevent rejection. The goal was to see if patients could avoid long-term steroids and calcineurin inhibitors. Twenty first-time kidney transplant recipient…